Artigos de revistas sobre o tema "Biopsy-based transcriptomics"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Biopsy-based transcriptomics".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Ungar, B., M. Yavzori, E. Fudim, O. Picard, U. Kopylov, R. Eliakim, D. Shouval et al. "P032 Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients". Journal of Crohn's and Colitis 16, Supplement_1 (1 de janeiro de 2022): i152—i153. http://dx.doi.org/10.1093/ecco-jcc/jjab232.161.
Texto completo da fonteDan, S., B. Ungar, S. Ben-Moshe, K. Bahar Halpern, M. Yavzori, E. Fudim, O. Picard et al. "P017 Fecal wash host transcriptomics identifies inflammation throughout the colon and terminal ileum". Journal of Crohn's and Colitis 17, Supplement_1 (30 de janeiro de 2023): i188. http://dx.doi.org/10.1093/ecco-jcc/jjac190.0147.
Texto completo da fonteVoutetakis, Konstantinos, Aristotelis Chatziioannou, Efstathios S. Gonos e Ioannis P. Trougakos. "Comparative Meta-Analysis of Transcriptomics Data during Cellular Senescence andIn VivoTissue Ageing". Oxidative Medicine and Cellular Longevity 2015 (2015): 1–17. http://dx.doi.org/10.1155/2015/732914.
Texto completo da fonteDinis Fernandes, Catarina, Annekoos Schaap, Joan Kant, Petra van Houdt, Hessel Wijkstra, Elise Bekers, Simon Linder et al. "Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer". Cancers 15, n.º 12 (6 de junho de 2023): 3074. http://dx.doi.org/10.3390/cancers15123074.
Texto completo da fonteCherry, Hannah, Joe Rastrick, Joanna Jacków, Maddy Parsons e John McGrath. "O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways". British Journal of Dermatology 190, n.º 6 (17 de maio de 2024): e78-e79. http://dx.doi.org/10.1093/bjd/ljae105.022.
Texto completo da fonteBoldanova, Tuyana, Geoffrey Fucile, Jan Vosshenrich, Aleksei Suslov, Caner Ercan, Mairene Coto-Llerena, Luigi M. Terracciano et al. "Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization". Cell Reports Medicine 2, n.º 11 (novembro de 2021): 100444. http://dx.doi.org/10.1016/j.xcrm.2021.100444.
Texto completo da fonteZhang, Yueyun, Carlos Henrique Venturi Ronchi, Giovanna Ambrosini, Yuanlong Liu, Patrick Aouad, Daria Matvienko, Christoph Merten e Cathrin Brisken. "Abstract PO5-14-06: Transcriptomics-based drug screening in 3D ex vivo patient-drived breast cancer model and patient biopsy for personalized therapy". Cancer Research 84, n.º 9_Supplement (2 de maio de 2024): PO5–14–06—PO5–14–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-14-06.
Texto completo da fonteCimadamore, Alessia, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli e Rodolfo Montironi. "Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy". Cancers 11, n.º 2 (7 de fevereiro de 2019): 196. http://dx.doi.org/10.3390/cancers11020196.
Texto completo da fonteDas, Sreyashi, Mohan Kumar Dey, Ram Devireddy e Manas Ranjan Gartia. "Biomarkers in Cancer Detection, Diagnosis, and Prognosis". Sensors 24, n.º 1 (20 de dezembro de 2023): 37. http://dx.doi.org/10.3390/s24010037.
Texto completo da fontevan Bergen, Cornelis A. M., Marvyn T. Koning, Edwin Quinten, Agnieszka Mykowiecka, Julieta Sepulveda, Ramin Monajemi, Ruben A. L. De Groen et al. "High-Throughput BCR Sequencing and Single-Cell Transcriptomics Reveal Distinct Transcriptional Profiles Associated with Subclonal Evolution of Follicular Lymphoma". Blood 134, Supplement_1 (13 de novembro de 2019): 298. http://dx.doi.org/10.1182/blood-2019-130508.
Texto completo da fonteKersch, Cymon, Cheryl Claunch, Prakash Ambady, Elmar Bucher, Daniel Schwartz, Ramon Barajas, Jeffrey Iliff, Laura Heiser, Leslie Muldoon e Edward Neuwelt. "PATH-63. TRANSCRIPTIONAL SIGNATURES IN HISTOLOGIC STRUCTURES WITHIN GLIOBLASTOMA TUMORS MAY PREDICT PERSONALIZED TREATMENT SENSITIVITY AND SURVIVAL". Neuro-Oncology 21, Supplement_6 (novembro de 2019): vi157. http://dx.doi.org/10.1093/neuonc/noz175.658.
Texto completo da fonteLee, Irene Tai-Lin, Chin-Hsuan Shen, Feng-Chiao Tsai, Chun-Bing Chen e Kevin Sheng-Kai Ma. "Cancer-Derived Extracellular Vesicles as Biomarkers for Cutaneous Squamous Cell Carcinoma: A Systematic Review". Cancers 14, n.º 20 (18 de outubro de 2022): 5098. http://dx.doi.org/10.3390/cancers14205098.
Texto completo da fonteKretschmer-Kazemi Far, Rosel, Kirsten Frank e Georg Sczakiel. "Sampling, Logistics, and Analytics of Urine for RT-qPCR-based Diagnostics". Cancers 13, n.º 17 (30 de agosto de 2021): 4381. http://dx.doi.org/10.3390/cancers13174381.
Texto completo da fonteCook, Daniel, Dorys Lopez, Anu K. Antony, The SimBioSys Team e John A. Cole. "Multimodal approach to capture spatially resolved single-cell tumor heterogeneity in breast cancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e12597-e12597. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e12597.
Texto completo da fonteCook, Daniel, Dorys Lopez, Anu K. Antony, The SimBioSys Team e John A. Cole. "Multimodal approach to capture spatially resolved single-cell tumor heterogeneity in breast cancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e12597-e12597. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e12597.
Texto completo da fonteGjyrezi, Ada, Charalampos Skarlis, Paul Zumbo, Doron Betel, Ioanna E. Stergiou, Michael Voulgarelis, Clio P. Mavragani e Paraskevi Giannakakou. "Abstract 1404: Blood-based transcriptomics provides novel insights into Sjögren's syndrome-associated lymphomagenesis". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 1404. http://dx.doi.org/10.1158/1538-7445.am2024-1404.
Texto completo da fonteYohihara, R., H. Tsuchiya, Y. Omata, H. Takahashi, S. Nakajima, H. Mizuhara, A. Uchio et al. "POS1014 INVESTIGATING THE SYNOVIAL PATHOLOGY RELATED TO TREATMENT RESISTANCE IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS USING SINGLE-CELL ANALYSIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 823.1–823. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1112.
Texto completo da fonteOrsini, Arianna, Chiara Diquigiovanni e Elena Bonora. "Omics Technologies Improving Breast Cancer Research and Diagnostics". International Journal of Molecular Sciences 24, n.º 16 (11 de agosto de 2023): 12690. http://dx.doi.org/10.3390/ijms241612690.
Texto completo da fonteMiller, Dulaney, Kyle Manning, Shuran Xing, T. Jeffrey Cole, Christopher J. Benway, Elena M. Cortizas, J. Christian J. Ray et al. "Stratification of patients with prostate cancer using a comprehensive multiomic approach: Integrating extracellular vesicle transcriptomics profiling with cfDNA methylation in urine-based liquid biopsy." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): e17095-e17095. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e17095.
Texto completo da fonteQuek, Camelia, Aditya Pratapa, Ines Pires da Silva, Ghamdan Al-Eryani, Aaron Mayer, Nenad Bartonicek, Kate Harvey et al. "Abstract 4621: Distinct spatial and molecular maps in the tumour microenvironment of resistant melanoma patients treated with checkpoint inhibitor immunotherapy". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 4621. http://dx.doi.org/10.1158/1538-7445.am2023-4621.
Texto completo da fonteFRENEL, Jean Sebastien, Fadoua Ben Azzouz, Frederic Bigot, Jonathan Dauve, Marie Francoise Heymann, Wilfried Gouraud, Catherine Guette et al. "Abstract P5-02-37: Multi-omics approach to identify markers of resistance to endocrine therapy + CDK4/6 inhibitors in first line HR+/HER2- metastatic breast cancer (MBC) patients". Cancer Research 83, n.º 5_Supplement (1 de março de 2023): P5–02–37—P5–02–37. http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-02-37.
Texto completo da fonteNeagu, Anca-Narcisa, Danielle Whitham, Pathea Bruno, Hailey Morrissiey, Celeste A. Darie e Costel C. Darie. "Omics-Based Investigations of Breast Cancer". Molecules 28, n.º 12 (14 de junho de 2023): 4768. http://dx.doi.org/10.3390/molecules28124768.
Texto completo da fonteChang, Ming-Ling, e Sien-Sing Yang. "Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology". Cells 8, n.º 11 (12 de novembro de 2019): 1423. http://dx.doi.org/10.3390/cells8111423.
Texto completo da fonteDu, Mulong. "Prospective of Mitochondrial DNA Variations in Cancer on Genomic Medicine". Cancer Epidemiology, Biomarkers & Prevention 33, n.º 6 (3 de junho de 2024): 766–68. http://dx.doi.org/10.1158/1055-9965.epi-24-0233.
Texto completo da fonteReis Nisa, P. I., C. Mahony, C. Smith, C. D. Buckley, K. Raza, A. Filer, D. Windell, M. Coles e A. Croft. "OP0094 SPATIAL POSITIONING AND MATRIX PROGRAMS OF SYNOVIAL FIBROBLASTS UNDERPIN IMMUNE CELL ORGANISATION AND SYNOVIAL TISSUE PATHOTYPE". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 64.2–64. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6114.
Texto completo da fonteLin, Pei-Hsuan, Wan-Ping Su, Chia-Jung Li, Li-Te Lin, Jim Jinn-Chyuan Sheu, Zhi-Hong Wen, Jiin-Tsuey Cheng e Kuan-Hao Tsui. "Investigating the Role of Ferroptosis-Related Genes in Ovarian Aging and the Potential for Nutritional Intervention". Nutrients 15, n.º 11 (25 de maio de 2023): 2461. http://dx.doi.org/10.3390/nu15112461.
Texto completo da fonteSitnikova, Suzanne Isabelle, Sophie Munnings-Tomes, Elena Galvani, Stacy Kentner, Kathy Mulgrew, Chris Rands, Judit España Agustí et al. "Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models". Journal for ImmunoTherapy of Cancer 9, n.º 6 (junho de 2021): e002894. http://dx.doi.org/10.1136/jitc-2021-002894.
Texto completo da fonteImai, Mitsuho, Jinyeong Lim, Naoko Iida, Hiromichi Ebi, Wataru Okamoto, Takeshi Kato, Taito Esaki et al. "Deciphering tumor microenvironment dynamics in HER2-amplified refractory metastatic colorectal cancer in the TRIUMPH trial." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): 3564. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3564.
Texto completo da fonteNaing, Aung, Hirva Mamdani, Minal A. Barve, Melissa Lynne Johnson, Sam Darko, Julie A. Murphy, Lauren Trogun et al. "Investigation of a potential protein biomarker signature that may predict clinical benefit of NT-I7 and pembrolizumab in patients with cold gastrointestinal tumors." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): 2563. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.2563.
Texto completo da fonteTesfaye, D., N. Ghanem, F. Rings, E. Tholen, C. Phatsara, K. Schellander e M. Hoelker. "196 EMBRYO BIOPSY TRANSCRIPTOMICS: A POTENTIAL TOOL TO IDENTIFY TRANSCRIPTS DIRECTLY RELATED TO THE ABILITY OF THE EMBRYO TO INDUCE PREGNANCY AFTER TRANSFER". Reproduction, Fertility and Development 21, n.º 1 (2009): 196. http://dx.doi.org/10.1071/rdv21n1ab196.
Texto completo da fonteBojmar, Linda, Constantinos P. Zambirinis, Jonathan Hernandez, Jayasree Chakraborty, Samer Hanna, Diane Simeone, David Kelsen et al. "Abstract PR012: Perioperative liver biopsy captures features of the liver pre-metastatic niche and predicts metastatic outcome after pancreatic cancer resection". Cancer Research 82, n.º 22_Supplement (15 de novembro de 2022): PR012. http://dx.doi.org/10.1158/1538-7445.panca22-pr012.
Texto completo da fonteTreaba, Diana O., Dennis M. Bonal, Anna D. Chorzalska, Christoph Schorl, Kelsey Hopkins, John L. Reagan, Peter Rintels, Peter J. Quesenberry e Patrycja M. Dubielecka. "Levels of Osteopontin (SPP1), Osteonectin (SPARC) and Biglycan (BGN) in Acute Myeloid Leukemia Bone Marrow Biopsies Post-Induction Therapy Define the Status of Osteogenic Niche and Show Inverse Correlation with Therapeutic Response". Blood 136, Supplement 1 (5 de novembro de 2020): 29–30. http://dx.doi.org/10.1182/blood-2020-142604.
Texto completo da fonteNikfar, Mehdi, Haoyang Mi, Chang Gong, Holly Kimko e Aleksander S. Popel. "Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model". Cancers 15, n.º 10 (13 de maio de 2023): 2750. http://dx.doi.org/10.3390/cancers15102750.
Texto completo da fonteClemenceau, Jean R., Paola Suarez Meade, Mark E. Jentoft, Alfredo Quiñones-Hinojosa e Tae Hyun Hwang. "Abstract 144: Spatial transcriptomic landscape of the primary and recurrent glioblastoma tumor microenvironment". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 144. http://dx.doi.org/10.1158/1538-7445.am2023-144.
Texto completo da fonteAnderson, Chiron J., e Stephan Schmitz-Esser. "41 Differential Gene Expression of the Bovine Rumen Epithelial Microbiota During a Sub-acute Ruminal Acidosis (SARA) Challenge". Journal of Animal Science 100, Supplement_2 (12 de abril de 2022): 12. http://dx.doi.org/10.1093/jas/skac064.018.
Texto completo da fonteLopez-Escalera, Silvia, Mari L. Lund, Gerben D. A. Hermes, Béatrice S. Y. Choi, Kei Sakamoto e Anja Wellejus. "In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention". Nutrients 15, n.º 10 (18 de maio de 2023): 2361. http://dx.doi.org/10.3390/nu15102361.
Texto completo da fonteKugler, M., M. Dellinger, F. Kartnig, L. Müller, T. Preglej, L. Heinz, E. Simader et al. "AB0056 CYTOKINE-DIRECTED CELLULAR CROSSTALK IMPRINTS SYNOVIAL PATHOTYPES IN RHEUMATOID ARTHRITIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 1207.2–1207. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6440.
Texto completo da fonteRing, Alexander, Daniel Campo, Tania B. Porras, Pushpinder Kaur, Victoria A. Forte, Debu Tripathy, Janice Lu et al. "Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer". Annals of Surgical Oncology 29, n.º 5 (9 de janeiro de 2022): 2882–94. http://dx.doi.org/10.1245/s10434-021-11135-2.
Texto completo da fonteChen, L., C. Zhang, R. Niu, R. Mao, Y. Qiu e R. Feng. "P915 Multi-Omics Biomarkers for the Prediction of Response to Biologics in Patients with Inflammatory Bowel Disease". Journal of Crohn's and Colitis 18, Supplement_1 (1 de janeiro de 2024): i1670—i1671. http://dx.doi.org/10.1093/ecco-jcc/jjad212.1045.
Texto completo da fontePatil, Madhuri. "What is the Optimum Endometrium Needed for Implantation?" Fertility & Reproduction 05, n.º 04 (dezembro de 2023): 290. http://dx.doi.org/10.1142/s2661318223741048.
Texto completo da fonteYu, Liping. "Abstract 1393: A Novel platform providing automated, consistent and gentle cell isolation from tissues for downstream applications". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 1393. http://dx.doi.org/10.1158/1538-7445.am2022-1393.
Texto completo da fonteBahrambeigi, Vahid, Jaewon J. Lee, Kimal I. Rajapakshe, Bret M. Stephens, Jason T. Henry, Sarah Dhebat, Mark W. Hurd et al. "Abstract PR013: Transcriptomic profiling of liquid biopsy in colorectal cancer". Cancer Research 82, n.º 23_Supplement_1 (1 de dezembro de 2022): PR013. http://dx.doi.org/10.1158/1538-7445.crc22-pr013.
Texto completo da fonteIwamoto, F., O. Al Dalahmah, K. Manjrekar, C. Levrero, R. Michel, A. Bargo, S. Kaesshaefer et al. "P11.82.A TARGETING THE GLIOBLASTOMA MASTER REGULATOR C/EBPß: A PHARMACOKINETIC AND PHARMACODYNAMIC NEOADJUVANT STUDY OF ST101". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii95. http://dx.doi.org/10.1093/neuonc/noad137.316.
Texto completo da fonteHasanov, Elshad, Lesley Flynt, Rebecca Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle Wood, Travis Solley et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC." Journal of Clinical Oncology 42, n.º 4_suppl (1 de fevereiro de 2024): TPS496. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.tps496.
Texto completo da fonteJonasch, Eric, Elshad Hasanov, Lesley Flynt, Hyunsoo Hwang, Rebecca Slack Tidwell, Roserika Brooks, Lauren Michelle Wood et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): TPS4610. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps4610.
Texto completo da fonteCampbell, Katie M., Zaid Bustami, Daniel G. Chen, Egmidio Medina, Cynthia R. Gonzalez, Nataly Naser Aldeen, Ignacio Baselga-Carretero et al. "Abstract 6550: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 6550. http://dx.doi.org/10.1158/1538-7445.am2024-6550.
Texto completo da fonteGenta, Sofia, Ming Sound Tsao, Ben X. Wang, Aaron Richard Hansen, Trevor John Pugh, Mathieu Lupien, Bryan Coburn et al. "Immune Resistance Interrogation Study (IRIS): A prospective comprehensive multi-omic analysis in patients with intrinsic and acquired resistance to immunotherapy." Journal of Clinical Oncology 39, n.º 15_suppl (20 de maio de 2021): TPS2679. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.tps2679.
Texto completo da fonteHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle Wood, Travis Solley et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junho de 2023): TPS4605. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps4605.
Texto completo da fonteHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle King, Travis Solley et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC." Journal of Clinical Oncology 41, n.º 6_suppl (20 de fevereiro de 2023): TPS749. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps749.
Texto completo da fonteHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren King, Travis Solley et al. "STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC". Oncologist 28, Supplement_1 (23 de agosto de 2023): S13. http://dx.doi.org/10.1093/oncolo/oyad216.021.
Texto completo da fonte